Acura Pharmaceuticals reported -300000 in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acelrx Pharmaceuticals ACRX:US $ -8995000 820K
Acura Pharmaceuticals ACUR:US -300000 154K
Intra Cellular Therapies ITCI:US $ -72662000 13.34M
Johnson & Johnson JNJ:US $ 7540M 1623M
Nektar Therapeutics NKTR:US $ -115085000 2.17M
Pfizer PFE:US $ 9995M 4136M
Rigel Pharmaceuticals RIGL:US $ -26261000 8.36M
Shionogi 4507:JP 49.89B 32.13B
Sun Pharmaceuticals SUNP:IN 16.23B 4.4B
Teva Pharmaceutical TEVA:IT 789M 182M
Xeris Pharmaceuticals Inc XERS:US $ -19074000 27M